Increased prevalence of ventricular septal defect: epidemic or improved diagnosis

Related Experiment Video

Updated: Sep 23, 2026

Murine Fetal Echocardiography
08:04

Murine Fetal Echocardiography

Published on: February 15, 2013

G R Martin1, L W Perry, C Ferencz

  • 1Department of Pediatric Cardiology, George Washington University, Washington, DC.

Pediatrics
|February 1, 1989
PubMed

Insights

An increase in infant ventricular septal defects was observed, but this rise in congenital heart defects is attributed to improved echocardiography detection, not an epidemic. Early diagnosis of isolated defects has increased.

Area of Science:

  • Pediatric Cardiology
  • Epidemiology
  • Medical Diagnostics

Background:

  • The Baltimore-Washington Infant Study monitors congenital cardiovascular malformations.
  • An increase in ventricular septal defects (VSDs) was noted between 1981 and 1984.

Purpose of the Study:

  • To investigate the rise in VSD prevalence among infants.
  • To determine if the increase in congenital heart defects signifies an epidemic.

Main Methods:

  • A case-control study analyzing data from 1,494 infants with confirmed diagnoses.
  • Diagnoses confirmed via echocardiography, catheterization, surgery, or autopsy.
  • Prevalence rates per 1,000 live births were calculated and compared over time.

Main Results:

  • Overall congenital cardiovascular malformations increased from 3.6 to 4.5 per 1,000 live births (P < .025).
  • VSD prevalence rose from 1.0 to 1.6 per 1,000 live births (P < .001), accounting for the total increase.
  • Isolated VSD prevalence increased significantly (0.67 to 1.17 per 1,000 live births, P < .001).
  • No change in VSD with specific co-occurring conditions; no change in VSDs diagnosed via catheterization, surgery, or autopsy.
  • VSDs diagnosed by echocardiography increased from 0.30 to 0.70 per 1,000 live births (P < .001).

Conclusions:

  • The reported increase in VSD prevalence is primarily due to enhanced detection of small, isolated defects using echocardiography.
  • There is no evidence to support an epidemic of congenital heart defects.
  • Improved diagnostic capabilities, particularly echocardiography, are key to understanding changing prevalence rates.

Related Concept Videos

Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...